JOHNSON & JOHNSON 8-K

What Happened
Johnson & Johnson (JNJ) filed an 8‑K reporting the results of its 2026 Annual Meeting of Shareholders held April 23, 2026. Shareholders elected all 12 director nominees named in the proxy, including CEO Joaquin Duato, approved the advisory "say-on-pay" vote, ratified PricewaterhouseCoopers LLP as the company’s independent auditor for fiscal 2026, and rejected a shareholder proposal to require an independent board chair.

Key Details

• Date of meeting: April 23, 2026. All 12 director nominees were elected (final vote tallies were reported for each nominee).
• Advisory vote on executive compensation (Say on Pay): For 1,641,173,032; Against 91,774,923; Abstained 9,607,174.
• Ratification of PricewaterhouseCoopers LLP as independent auditor for 2026: For 1,914,846,474; Against 138,633,899; Abstained 3,481,479.
• Shareholder proposal to adopt a policy requiring an independent board chair was not approved: For 406,353,048; Against 1,326,857,173; Abstained 9,344,908.

Why It Matters
These results show investor support for the current Board and management team (including CEO Joaquin Duato) and for the company’s executive compensation approach. Ratification of PwC confirms continuity in external audit oversight for fiscal 2026. The rejection of the independent‑chair proposal means J&J’s board governance structure will remain as currently organized, which is a governance outcome investors may consider when evaluating board accountability and oversight.